Molecular Epidemiology of Hepatitis B Virus in Turkish Cypriot

Publications

Share / Export Citation / Email / Print / Text size:

Polish Journal of Microbiology

Polish Society of Microbiologists

Subject: Microbiology

GET ALERTS

ISSN: 1733-1331
eISSN: 2544-4646

DESCRIPTION

0
Reader(s)
0
Visit(s)

Comment(s)
0
Share(s)

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue / page

Related articles

VOLUME 68 , ISSUE 4 (Jan 2019) > List of articles

Molecular Epidemiology of Hepatitis B Virus in Turkish Cypriot

UNAL SUMER * / MURAT SAYAN

Keywords : hepatitis B Virus, genotype, drug resistance, hepatitis B surface antigens

Citation Information : Polish Journal of Microbiology. Volume 68, Issue 4, Pages 449-456, DOI: https://doi.org/10.33073/pjm-2019-044

License : (CC-BY-NC-ND 4.0)

Published Online: 22-October-2019

ARTICLE

ABSTRACT

Content not available Share

FIGURES & TABLES

REFERENCES

  1. Al-Sadeq DW, Taleb SA, Zaied RE, Fahad SM, Smatti MK, Rizeq BR, Al Thani AA, Yassine HM, Nasrallah GK. Hepatitis B virus molecular epidemiology, host-virus interaction, coinfection, and laboratory diagnosis in the MENA Region: an update. Pathogens. 2019 May 11;8(2):63. https://doi.org/10.3390/pathogens8020063
    [CROSSREF]
  2. Arikan A, Şanlidağ T, Süer K, Sayan M, Akçali S, Güler E. [Molecular epidemiology of hepatitis B virus in Northern Cyprus] (in Turkish). Mikrobiyol Bul. 2016 Jan 7;50(1):86–93. https://doi.org/10.5578/mb.10292
    [PUBMED] [CROSSREF]
  3. Arikan A. Nucleostide analogue resistance and genotype/sub genotype dispersion of treatment naïve hepatitis B patients in Northern Cyprus [PhD thesis]. Institute of Health and Medical Sciences, Near East University, Nicosia; 2015.
  4. Asan A, Sayan M, Akhan S, Tekin Koruk S, Aygen B, Sirmatel F, Eraksoy H, Tuna N, Köse S, Kaya A, et al. Molecular characterization of drug resistance in hepatitis B viruses isolated from patients with chronical infection in Turkey. Hepat Mon. 2018 Jan 24;18(1):e12472. https://doi.org/10.5812/hepatmon.12472
    [CROSSREF]
  5. Bissinger AL, Fehrle C, Werner CR, Lauer UM, Malek NP, Berg CP. Epidemiology and genotyping of patients with chronic Hepatitis B: genotype shifting observed in patients from Central Europe. Pol J Microbiol. 2015;64(1):15–21.
    [PUBMED] [CROSSREF]
  6. Chacha SGF, Gomes-Gouvêa MS, Malta FM, Ferreira SDC, Villanova MG, Souza FF, Teixeira AC, Passos ADDC, Pinho JRR, Martinelli ALC. Distribution on HBV sungenotypes in Ribeirao Preto, Southeastern Brazil: a region with history of intense Italian immigration. Braz J Infect Dis. 2017;21(4):424–432. https://doi.org/10.1016/j.bjid.2017.01.011
    [PUBMED] [CROSSREF]
  7. Cheah BC, Davies J, Singh GR, Wood N, Jackson K, Littlejohn M, Davison B, McIntyre P, Locarnini S, Davis JS, et al. Sub-optimal protection against past hepatitis B virus infection where subtype mismatch exists between vaccine and circulating viral genotype in northern Australia. Vaccine. 2018 Jun;36(24):3533–3540. https://doi.org/10.1016/j.vaccine.2018.01.062
    [PUBMED] [CROSSREF]
  8. Christou J. Foreign students propel sharp population increase in north. Cyprus Mail [Internet]. 2018 Apr 3 [cited 2018 Dec 28]. Available from https://cyprus-mail.com/2018/04/03/foreign-students-propel-sharp-population-increase-north/
  9. Kaptanoğlu AF, Süer K, Diktaş H, Hınçal E. Knowledge, atti tudes and behaviour towards sexually transmitted diseases in Turkish Cypriot adolescents. Cent Eur J Public Health. 2013 Mar 1;21(1):54–58. https://doi.org/10.21101/cejph.a3808
    [CROSSREF]
  10. KKTC Sağlık Bakanlığı. 2019 [cited 2019 Feb 2]. Available from http://saglik.gov.ct.tr/
  11. Kostaki EG, Karamitros T, Stefanou G, Mamais I, Angelis K, Hatzakis A, Kramvis A, Paraskevis D. Unravelling the history of hepatitis B virus genotypes A and D infection using a full-genome phylogenetic and phylogeographic approach. eLife. 2018 Aug 07; 7:e36709. https://doi.org/10.7554/eLife.36709
    [CROSSREF]
  12. Kramvis A, Kew M, François G. Hepatitis B virus genotypes. Vaccine. 2005 Mar;23(19):2409–2423. https://doi.org/10.1016/j.vaccine.2004.10.045
    [CROSSREF]
  13. Kurugöl Z, Koturoğlu G, Akşit S, Ozacar T, Kayimbaşoğlu S, Ozbalikçi S, Erçal G, Güllüelli E, Bakkaloğlu F, Doğan E, et al.; Northern Cyprus Study Team. Seroprevalence of hepatitis B infection in the Turkish population in Northern Cyprus. Turk J Pediatr. 2009 Mar-Apr;51(2):120–126.
    [PUBMED]
  14. Lazarevic I. Clinical implications of hepatitis B virus mutations: recent advances. World J Gastroenterol. 2014;20(24):7653–7664. https://doi.org/10.3748/wjg.v20.i24.7653
    [PUBMED] [CROSSREF]
  15. Özgüler M, Sayan M. Could resistant and escape variants of hepatitis B virus be a problem in the future? Future Virol. 2018 Mar; 13(3):171–179. https://doi.org/10.2217/fvl-2017-0144
    [CROSSREF]
  16. Paoli J, Wortmann AC, Klein MG, Pereira VRZB, Cirolini AM, Godoy BA, Fagundes NJR, Wolf JM, Lunge VR, Simon D. HBV epidemiology and genetic diversity in an area of high prevalence of hepatitis B in southern Brazil. Braz J Infect Dis. 2018 Jul;22(4):294–304. https://doi.org/10.1016/j.bjid.2018.06.006
    [PUBMED] [CROSSREF]
  17. Sayan M, Akhan SC, Senturk O. Frequency and mutation patterns of resistance in patients with chronic hepatitis B infection treated with nucleos(t)ide analogs in add-on and switch strategies. Hepat Mon. 2011 Oct 01;11(10):835–842. https://doi.org/10.5812/kowsar.1735143X.1004
    [PUBMED]
  18. Sayan M, Buğdaci MS. [HBV vaccine escape mutations in a chro nic hepatitis B patient treated with nucleos(t)ide analogues] (in Turkish). Mikrobiyol Bul. 2013 Jul 29;47(3):544–549. https://doi.org/10.5578/mb.5442
    [PUBMED] [CROSSREF]
  19. Sayan M, Cavdar C, Dogan C. Naturally occurring polymerase and surface gene variants of hepatitis B virus in Turkish hemodialysis patients with chronic hepatitis B. Jpn J Infect Dis. 2012;65(6):495–501. https://doi.org/10.7883/yoken.65.495
    [PUBMED] [CROSSREF]
  20. Sayan M, Şanlidağ T, Akçali S, Arikan A. [Hepatitis B virus geno type E infection in Turkey: the detection of the first case] (in Turkish). Mikrobiyol Bul. 2014 Oct 28;48(4):683–688. https://doi.org/10.5578/mb.4769
    [PUBMED] [CROSSREF]
  21. Sayan M, Şentürk Ö, Akhan SÇ, Hülagü S, Çekmen MB. Monitoring of hepatitis B virus surface antigen escape mutations and concomitantly nucleos(t)ide analog resistance mutations in Turkish patients with chronic hepatitis B. Int J Infect Dis. 2010 Sep; 14 Suppl 3:136-e141. https://doi.org/10.1016/j.ijid.2009.11.039
    [CROSSREF]
  22. Sayan M. Molecular diagnosis of entecavir resistance. Hepat Mon. 2010;10(1):42–47.
    [PUBMED]
  23. Sayiner A, Abacioglu H. Epidemiology of hepatitis B in Turkey. In: Van Damme P, Vorsters A, Van Herck K, Hendrickx G, editors. Viral Hepatitis. Antwerp (Belgium): Viral hepatitis prevention board; 2010;18(2). p. 5–7.
  24. Sunbul M. Hepatitis B virus genotypes: global distribution and clinical importance. World J Gastroenterol. 2014;20(18):5427–5434. https://doi.org/10.3748/wjg.v20.i18.5427
    [PUBMED] [CROSSREF]
  25. Tallo T, Tefanova V, Priimägi L, Schmidt J, Katargina O, Michailov M, Mukomolov S, Magnius L, Norder H. D2: major subgenotype of hepatitis B virus in Russia and the Baltic region. J Gen Virol. 2008 Aug 01;89(8):1829–1839. https://doi.org/10.1099/vir.0.83660-0
    [PUBMED] [CROSSREF]
  26. U.S. Department of State Publication. Trafficking in persons report. United States Department of State, Office of the Under Secretary for Civilian Security, Democracy, and Human Rights (USA): A/GIS/GPS; 2018. p. 159–162.
  27. Velkov S, Ott J, Protzer U, Michler T. The global hepatitis B virus genotype distribution approximated from available genotyping data. Genes (Basel). 2018 Oct 15;9(10):495. https://doi.org/10.3390/genes9100495
    [CROSSREF]
  28. WHO. Hepatitis B [Internet]. Geneva (Switzerland): World Health Organization; 2019 [cited 2019 Jul 23]. Available from https://www.who.int/news-room/fact-sheets/detail/hepatitis-b
  29. World Population Review. Cyprus Population. Walnut (USA): World Population Review; 2018 [cited 2018 Dec 28]. Available from http://worldpopulationreview.com/countries/cyprus-population/
  30. Yokosuka O, Arai M. Molecular biology of hepatitis B virus: effect of nucleotide substitutions on the clinical features of chronic hepatitis B. Med Mol Morphol. 2006 Sep 26;39(3):113–120. https://doi.org/10.1007/s00795-006-0328-5
    [CROSSREF]
  31. Zamor PJ, deLemos AS, Russo MW. Viral hepatitis and hepa tocellular carcinoma: etiology and management. J Gastrointest Oncol. 2017 Apr;8(2):229–242. https://doi.org/10.21037/jgo.2017.03.14
    [CROSSREF]
  32. Zehender G, Ebranati E, Gabanelli E, Sorrentino C, Lo Presti A, Tanzi E, Ciccozzi M, Galli M. Enigmatic origin of hepatitis B virus: an ancient travelling companion or a recent encounter? World J Gastroenterol. 2014;20(24):7622–7634. https://doi.org/10.3748/wjg.v20.i24.7622
    [CROSSREF]

EXTRA FILES

COMMENTS